Cargando…

Unusual expansion of CD3+CD56+ natural killer T-like cells in peripheral blood after anticytokine treatment for graft-versus-host disease: A case report

RATIONALE: Basiliximab and etanercept have achieved promising responses in steroid-refractory graft versus host disease (SR-GVHD). However, the in vivo immune changes following the treatment have not been elucidated. PATIENT CONCERNS: A 14-year-old boy presented with skin rash and diarrhea 20 days a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sheng, Lixia, Fu, Huarui, Tan, Yamin, Hu, Yongxian, Mu, Qitian, Luo, Yi, Shi, Jianmin, Cai, Zhen, Ouyang, Guifang, Huang, He
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160206/ https://www.ncbi.nlm.nih.gov/pubmed/30235723 http://dx.doi.org/10.1097/MD.0000000000012429

Ejemplares similares

Evaluation of CD56(dim) and CD56(bright) natural killer cells in peripheral blood of women with IVF failures
por: Mardanian, Farahnaz, et al.
Publicado: (2015)

Cytotoxicity of Donor Natural Killer Cells to Allo-Reactive T Cells Are Related With Acute Graft-vs.-Host-Disease Following Allogeneic Stem Cell Transplantation
por: Sheng, Lixia, et al.
Publicado: (2020)

Viral Anticytokine Strategies
por: Alcami, Antonio
Publicado: (2016)

Distinct Signatures in the Receptor Repertoire Discriminate CD56bright and CD56dim Natural Killer Cells
por: Schwane, Vera, et al.
Publicado: (2020)

CD56(bright)CD16(-) natural killer cells as an important regulatory mechanism in chronic graft-versus-host disease
por: Lauener, Madeline P., et al.
Publicado: (2022)

Update on Anticytokine Treatment for Asthma
por: Gallelli, Luca, et al.
Publicado: (2013)

Anticytokine Autoantibodies and Fungal Infections
por: Kappagoda, Shanthi, et al.
Publicado: (2023)

Impact of polysialylated CD56 on natural killer cell cytotoxicity
por: Moebius, Jeannette M, et al.
Publicado: (2007)

MicroRNA profiling of CD3(+)CD56(+) cytokine-induced killer cells
por: Wang, Wenju, et al.
Publicado: (2015)

Human Natural Killer Cell Maturation Defect Supports In Vivo CD56(bright) to CD56(dim) Lineage Development
por: Domaica, Carolina Inés, et al.
Publicado: (2012)

CD56(dim)CD16(dim) Natural Killer (NK) Cells: The Forgotten Population
por: Zimmer, Jacques
Publicado: (2020)

CD56(bright) natural killer cells preferentially kill proliferating CD4(+) T cells
por: Lee, Mercede, et al.
Publicado: (2023)

The phenotype of CD3–CD56(bright) and CD3–CD56(dim) natural killer cells in systemic lupus erythematosus patients and its relation to disease activity
por: Soelistyoningsih, Dwi, et al.
Publicado: (2022)

Human CD56(dim)CD16(dim) Cells As an Individualized Natural Killer Cell Subset
por: Amand, Mathieu, et al.
Publicado: (2017)

CD56 Is a Pathogen Recognition Receptor on Human Natural Killer Cells
por: Ziegler, Sabrina, et al.
Publicado: (2017)

Anticytokine Autoantibodies: Association with Infection and Immune Dysregulation
por: Knight, Vijaya, et al.
Publicado: (2016)

Expansion of CD16-Negative Natural Killer Cells in the Peripheral Blood of Patients with Metastatic Melanoma
por: Holtan, Shernan G., et al.
Publicado: (2011)

Identification of Cytolytic CD161(−)CD56(+) Regulatory CD8 T Cells in Human Peripheral Blood
por: Hu, Dan, et al.
Publicado: (2013)

Human Circulating and Tissue-Resident CD56(bright) Natural Killer Cell Populations
por: Melsen, Janine E., et al.
Publicado: (2016)

Alterations in the CD56(−) and CD56(+) T Cell Subsets during COVID-19
por: Vavilova, Julia D., et al.
Publicado: (2023)

Decreased CD3-CD16+CD56+ natural killer cell counts in children with orbital myositis: a clue to disease activity
por: Briones, Melissa R, et al.
Publicado: (2017)

Beyond Uterine Natural Killer Cell Numbers in Unexplained Recurrent Pregnancy Loss: Combined Analysis of CD45, CD56, CD16, CD57, and CD138
por: Chiokadze, Maia, et al.
Publicado: (2020)

Anticytokine therapy for periodontal diseases: Where are we now?
por: Waykole, Yogesh Prakash, et al.
Publicado: (2009)

Preventing COVID-19-induced pneumonia with anticytokine therapy
por: Monteleone, Giovanni, et al.
Publicado: (2020)

Profiling Serum Cytokines and Anticytokine Antibodies in Psoriasis Patients
por: Hong, Dan, et al.
Publicado: (2022)

The upregulation of peripheral CD3(-)CD56(+)CD16(+) natural killer cells correlates with Th1/Th2 imbalance in asthma patients during acute upper respiratory viral infections
por: Liu, Meixuan, et al.
Publicado: (2023)

CD300c is uniquely expressed on CD56(bright) Natural Killer Cells and differs from CD300a upon ligand recognition
por: Dimitrova, Milena, et al.
Publicado: (2016)

Contradictory Effect of Lymphocyte Therapy and Prednisolone Therapy on CD3(+)CD8(+)CD56(+) Natural Killer T Population in Women with Recurrent Spontaneous Abortion
por: Rezayat, Fatemeh, et al.
Publicado: (2023)

Evidence for the involvement of CD56 molecules in alloantigen-specific recognition by human natural killer cells
Publicado: (1991)

CD56(bright) natural killer cells and response to daclizumab HYP in relapsing-remitting MS
por: Elkins, J., et al.
Publicado: (2015)

Intratumoral CD56(bright) natural killer cells are associated with improved survival in bladder cancer
por: Mukherjee, Neelam, et al.
Publicado: (2018)

A long noncoding RNA positively regulates CD56 in human natural killer cells
por: Zhang, Ruya, et al.
Publicado: (2016)

Endometrial CD56+ natural killer cells in women with recurrent implantation failure: An immunohistochemical study
por: Babayeva, Gulchin, et al.
Publicado: (2020)

The early expansion of anergic NKG2A(pos)/CD56(dim)/CD16(neg) natural killer represents a therapeutic target in haploidentical hematopoietic stem cell transplantation
por: Roberto, Alessandra, et al.
Publicado: (2018)

CD3+, CD56+, CD4−, CD8−, CD20−, CD30− Peripheral T-Cell Non-Hodgkin's Lymphoma: A Rare Case Report
por: Jagati, Ashish, et al.
Publicado: (2017)

The frequencies of peripheral blood CD5(+)CD19(+) B cells, CD3(−)CD16(+)CD56(+) NK, and CD3(+)CD56(+) NKT cells and serum interleukin-10 in patients with multiple sclerosis and neuromyelitis optica spectrum disorder
por: Khani, Leila, et al.
Publicado: (2022)

Enriched CD45RA(−)CD62L(+) central memory T and decreased CD3(+)CD56(+) natural killer T lymphocyte subsets in the rectum of ulcerative colitis patients
por: Iwamuro, Masaya, et al.
Publicado: (2022)

Increased early activation of CD56(dim)CD16(dim/-) natural killer cells in immunological non-responders correlates with CD4(+) T-cell recovery
por: Zhang, Qiu-Yue, et al.
Publicado: (2020)

Primary gastric natural killer/T-cell lymphoma with diffuse CD30 expression and without CD56 expression: A case report
por: ZHANG, LIZHI, et al.
Publicado: (2016)

CD56(dim) CD16(−) Natural Killer Cell Profiling in Melanoma Patients Receiving a Cancer Vaccine and Interferon-α
por: Vujanovic, Lazar, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2h4q29o6ca2o170srilk67m02h